Turmeric : Curcumin, the active compound in turmeric, has been shown to stimulate GLP-1 release in the gut
Stepping down to tirzepatide (dual agonist) or semaglutide (single agonist) reduces total receptor activation
Key facts about retatrutide: Chemical class 39-amino-acid synthetic triple agonist (GLP-1 + GIP + glucagon receptor) Molecular weight approximately 4731 Da Developer Eli Lilly Half-life approximately 6 days (supports weekly dosing) Form typically supplied as lyophilized powder
Lilly Zepbound How to Use page (Lilly) acceptable tirzepatide injection sites, rotation guidance, pen/vial demonstration, and disposal tips
Combined with therapy, lifestyle interventions, and attention to inflammation and other biological factors, even modest doses can produce meaningful results with minimal side effects
GLP-1 Therapy and Cardiovascular Risk.